Global Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Region: Trend Forecast and Growth Opportunity

About the Report

About the Report

Global clinical diagnostics market will reach USD 135,531.4 million by 2031, growing by 7.4% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.

 

Highlighted with 82 tables and 94 figures, this 170-page report Global Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Region.

 

Based on Test, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Lipid Panel

Infectious Disease Testing

Liver Panel

Complete Blood Count (CBC)

Electrolyte Testing

Renal Panel

Other Tests

 

Based on Product, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Instruments

Assay Kits & Reagents

Software & Services

 

By Indication the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Cardiovascular

Cancer

Infectious Disease

Stroke

Chronic Lower Respiratory Diseases

Diabetes

Other Indications

 

By Patient Gender the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Male Patients

Female Patients

 

By Age Group the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Age 44 and below

Age 45-64

Age 65 and over

 

By End User the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Hospital & Clinics Laboratory

Diagnostic Laboratory

Point-of-Care Testing

Other End Users

 

Geographically, the following regions together with the listed national/local markets are fully investigated:

North America (U.S., Canada, and Mexico)

Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

South America (Brazil, Chile, Argentina, Rest of South America)

MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Test, Product, and Indication, over the forecast years are also included.

 

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories

Becton, Dickinson and Company

BioMerieux SA

Bio-Rad Laboratories Inc.

Bio-Reference Laboratories

Bioscientia Healthcare

Charles River Laboratories

Danaher Corporation

Hoffmann-La Roche AG

Hologic Inc.

Qiagen NV

Siemens Healthcare

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Selected Key Players:

Abbott Laboratories

Becton, Dickinson and Company

BioMerieux SA

Bio-Rad Laboratories Inc.

Bio-Reference Laboratories

Bioscientia Healthcare

Charles River Laboratories

Danaher Corporation

Hoffmann-La Roche AG

Hologic Inc.

Qiagen NV

Siemens Healthcare

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

Table of Contents

1 Introduction 9

1.1 Industry Definition and Research Scope 9

1.1.1 Industry Definition 9

1.1.2 Research Scope 10

1.2 Research Methodology 13

1.2.1 Overview of Market Research Methodology 13

1.2.2 Market Assumption 14

1.2.3 Secondary Data 14

1.2.4 Primary Data 14

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 21

2.1 Market Size and Forecast 21

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 26

2.3 Market Restraints and Challenges 32

2.4 Emerging Opportunities and Market Trends 35

2.5 Porter's Fiver Forces Analysis 39

3 Segmentation of Global Market by Test 43

3.1 Market Overview by Test 43

3.2 Lipid Panel 45

3.3 Infectious Disease Testing 46

3.4 Liver Panel 47

3.5 Complete Blood Count (CBC) 48

3.6 Electrolyte Testing 49

3.7 Renal Panel 50

3.8 Other Tests 51

4 Segmentation of Global Market by Product 52

4.1 Market Overview by Product 52

4.2 Instruments 54

4.3 Assay Kits & Reagents 55

4.4 Software & Services 56

5 Segmentation of Global Market by Indication 57

5.1 Market Overview by Indication 57

5.2 Cardiovascular 59

5.3 Cancer 60

5.4 Infectious Disease 61

5.5 Stroke 62

5.6 Chronic Lower Respiratory Diseases 63

5.7 Diabetes 64

5.8 Other Indications 65

6 Segmentation of Global Market by Patient Gender 66

6.1 Market Overview by Patient Gender 66

6.2 Male Patients 68

6.3 Female Patients 69

7 Segmentation of Global Market by Age Group 70

7.1 Market Overview by Age Group 70

7.2 Age 44 and below 72

7.3 Age 45-64 73

7.4 Age 65 and over 74

8 Segmentation of Global Market by End User 75

8.1 Market Overview by End User 75

8.2 Hospital & Clinics Laboratory 77

8.3 Diagnostic Laboratory 78

8.4 Point-of-Care Testing 79

8.5 Other End Users 80

9 Segmentation of Global Market by Region 81

9.1 Geographic Market Overview 2021-2031 81

9.2 North America Market 2021-2031 by Country 85

9.2.1 Overview of North America Market 85

9.2.2 U.S. 89

9.2.3 Canada 93

9.2.4 Mexico 95

9.3 European Market 2021-2031 by Country 97

9.3.1 Overview of European Market 97

9.3.2 Germany 101

9.3.3 U.K. 103

9.3.4 France 105

9.3.5 Spain 107

9.3.6 Italy 109

9.3.7 Russia 111

9.3.8 Rest of European Market 113

9.4 Asia-Pacific Market 2021-2031 by Country 115

9.4.1 Overview of Asia-Pacific Market 115

9.4.2 Japan 119

9.4.3 China 122

9.4.4 Australia 124

9.4.5 India 126

9.4.6 South Korea 128

9.4.7 Rest of APAC Region 130

9.5 South America Market 2021-2031 by Country 132

9.5.1 Argentina 135

9.5.2 Brazil 137

9.5.3 Chile 139

9.5.4 Rest of South America Market 141

9.6 MEA Market 2021-2031 by Country 142

9.6.1 UAE 145

9.6.2 Saudi Arabia 147

9.6.3 South Africa 149

9.6.4 Other National Markets 151

10 Competitive Landscape 152

10.1 Overview of Key Vendors 152

10.2 New Product Launch, Partnership, Investment, and M&A 155

10.3 Company Profiles 156

Abbott Laboratories 156

Becton, Dickinson and Company 158

BioMerieux SA 159

Bio-Rad Laboratories Inc. 160

Bio-Reference Laboratories 161

Bioscientia Healthcare 162

Charles River Laboratories 163

Danaher Corporation 164

Hoffmann-La Roche AG 165

Hologic Inc. 166

Qiagen NV 167

Siemens Healthcare 168

Thermo Fisher Scientific 169

RELATED REPORTS 170


List of Figure

List of Figures:

 

Figure 1. Research Method Flow Chart 13

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16

Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 18

Figure 4. Global Clinical Diagnostics Market, 2021-2031, USD mn 21

Figure 5. Impact of COVID-19 on Business 24

Figure 6. Primary Drivers and Impact Factors of Global Clinical Diagnostics Market 26

Figure 7. Leading Causes of Death in the World, 2019-2020, million 29

Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30

Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30

Figure 10. Primary Restraints and Impact Factors of Global Clinical Diagnostics Market 32

Figure 11. Investment Opportunity Analysis 36

Figure 12. Porter's Fiver Forces Analysis of Global Clinical Diagnostics Market 39

Figure 13. Breakdown of Global Clinical Diagnostics Market by Test, 2021-2031, % of Revenue 44

Figure 14. Global Addressable Market Cap in 2022-2031 by Test, Value (USD mn) and Share (%) 44

Figure 15. Global Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, USD mn 45

Figure 16. Global Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, USD mn 46

Figure 17. Global Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, USD mn 47

Figure 18. Global Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, USD mn 48

Figure 19. Global Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, USD mn 49

Figure 20. Global Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, USD mn 50

Figure 21. Global Clinical Diagnostics Market by Test: Other Tests, 2021-2031, USD mn 51

Figure 22. Breakdown of Global Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue 53

Figure 23. Global Addressable Market Cap in 2022-2031 by Product, Value (USD mn) and Share (%) 53

Figure 24. Global Clinical Diagnostics Market by Product: Instruments, 2021-2031, USD mn 54

Figure 25. Global Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, USD mn 55

Figure 26. Global Clinical Diagnostics Market by Product: Software & Services, 2021-2031, USD mn 56

Figure 27. Breakdown of Global Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue 58

Figure 28. Global Addressable Market Cap in 2022-2031 by Indication, Value (USD mn) and Share (%) 58

Figure 29. Global Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, USD mn 59

Figure 30. Global Clinical Diagnostics Market by Indication: Cancer, 2021-2031, USD mn 60

Figure 31. Global Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, USD mn 61

Figure 32. Global Clinical Diagnostics Market by Indication: Stroke, 2021-2031, USD mn 62

Figure 33. Global Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, USD mn 63

Figure 34. Global Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, USD mn 64

Figure 35. Global Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, USD mn 65

Figure 36. Breakdown of Global Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue 67

Figure 37. Global Addressable Market Cap in 2022-2031 by Patient Gender, Value (USD mn) and Share (%) 67

Figure 38. Global Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, USD mn 68

Figure 39. Global Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, USD mn 69

Figure 40. Breakdown of Global Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue 71

Figure 41. Global Addressable Market Cap in 2022-2031 by Age Group, Value (USD mn) and Share (%) 71

Figure 42. Global Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, USD mn 72

Figure 43. Global Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, USD mn 73

Figure 44. Global Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, USD mn 74

Figure 45. Breakdown of Global Clinical Diagnostics Market by End User, 2021-2031, % of Revenue 75

Figure 46. Global Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 76

Figure 47. Global Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, USD mn 77

Figure 48. Global Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, USD mn 78

Figure 49. Global Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, USD mn 79

Figure 50. Global Clinical Diagnostics Market by End User: Other End Users, 2021-2031, USD mn 80

Figure 51. Global Market Snapshot by Region 81

Figure 52. Geographic Spread of Worldwide Clinical Diagnostics Market, 2021-2031, % of Sales Revenue 82

Figure 53. Global Addressable Market Cap in 2022-2031 by Region, Value (USD mn) and Share (%) 83

Figure 54. North American Clinical Diagnostics Market, 2021-2031, USD mn 86

Figure 55. Breakdown of North America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 87

Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 88

Figure 57. U.S. Clinical Diagnostics Market, 2021-2031, USD mn 90

Figure 58. Percent Distribution of the 10 Leading Causes of Death by Gender in United States, 2019, % 90

Figure 59. Percent Distribution of the 10 Leading Causes of Death by Age Group in United States, 2019, % 91

Figure 60. Canada Clinical Diagnostics Market, 2021-2031, USD mn 93

Figure 61. Clinical Diagnostics Market in Mexico, 2021-2031, USD mn 95

Figure 62. European Clinical Diagnostics Market, 2021-2031, USD mn 98

Figure 63. Breakdown of European Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 99

Figure 64. Contribution to Europe 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 100

Figure 65. Clinical Diagnostics Market in Germany, 2021-2031, USD mn 101

Figure 66. Clinical Diagnostics Market in U.K., 2021-2031, USD mn 103

Figure 67. Clinical Diagnostics Market in France, 2021-2031, USD mn 105

Figure 68. Clinical Diagnostics Market in Spain, 2021-2031, USD mn 107

Figure 69. Clinical Diagnostics Market in Italy, 2021-2031, USD mn 109

Figure 70. Clinical Diagnostics Market in Russia, 2021-2031, USD mn 111

Figure 71. Clinical Diagnostics Market in Rest of Europe, 2021-2031, USD mn 113

Figure 72. Asia-Pacific Clinical Diagnostics Market, 2021-2031, USD mn 116

Figure 73. Breakdown of APAC Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 116

Figure 74. Contribution to APAC 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 118

Figure 75. Clinical Diagnostics Market in Japan, 2021-2031, USD mn 120

Figure 76. Clinical Diagnostics Market in China, 2021-2031, USD mn 122

Figure 77. Clinical Diagnostics Market in Australia, 2021-2031, USD mn 124

Figure 78. Clinical Diagnostics Market in India, 2021-2031, USD mn 126

Figure 79. Clinical Diagnostics Market in South Korea, 2021-2031, USD mn 128

Figure 80. Clinical Diagnostics Market in Rest of APAC, 2021-2031, USD mn 130

Figure 81. South America Clinical Diagnostics Market, 2021-2031, USD mn 133

Figure 82. Breakdown of South America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 133

Figure 83. Contribution to South America 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 134

Figure 84. Clinical Diagnostics Market in Argentina, 2021-2031, USD mn 135

Figure 85. Clinical Diagnostics Market in Brazil, 2021-2031, USD mn 137

Figure 86. Clinical Diagnostics Market in Chile, 2021-2031, USD mn 139

Figure 87. Clinical Diagnostics Market in Rest of South America, 2021-2031, USD mn 141

Figure 88. Clinical Diagnostics Market in Middle East and Africa (MEA), 2021-2031, USD mn 143

Figure 89. Breakdown of MEA Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 143

Figure 90. Contribution to MEA 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 144

Figure 91. Clinical Diagnostics Market in UAE, 2021-2031, USD mn 145

Figure 92. Clinical Diagnostics Market in Saudi Arabia, 2021-2031, USD mn 147

Figure 93. Clinical Diagnostics Market in South Africa, 2021-2031, USD mn 149

Figure 94. Growth Stage of Global Clinical Diagnostics Industry over the Forecast Period 152


List of Table

List of Tables:

 

Table 1. Snapshot of Global Clinical Diagnostics Market in Balanced Perspective, 2021-2031 19

Table 2. World Economic Outlook, 2021-2031 23

Table 3. World Health Spending by Region, USD bn, 2013-2020 31

Table 4. Main Product Trends and Market Opportunities in Global Clinical Diagnostics Market 35

Table 5. Global Clinical Diagnostics Market by Test, 2021-2031, USD mn 43

Table 6. Global Clinical Diagnostics Market by Product, 2021-2031, USD mn 52

Table 7. Global Clinical Diagnostics Market by Indication, 2021-2031, USD mn 57

Table 8. Global Clinical Diagnostics Market by Patient Gender, 2021-2031, USD mn 66

Table 9. Global Clinical Diagnostics Market by Age Group, 2021-2031, USD mn 70

Table 10. Global Clinical Diagnostics Market by End User, 2021-2031, USD mn 75

Table 11. Global Clinical Diagnostics Market by Region, 2021-2031, USD mn 82

Table 12. Leading National Clinical Diagnostics Market, 2021 and 2031, USD mn 84

Table 13. North America Clinical Diagnostics Market by Country, 2021-2031, USD mn 87

Table 14. U.S. Clinical Diagnostics Market by Test, 2021-2031, USD mn 92

Table 15. U.S. Clinical Diagnostics Market by Product, 2021-2031, USD mn 92

Table 16. U.S. Clinical Diagnostics Market by Indication, 2021-2031, USD mn 92

Table 17. Canada Clinical Diagnostics Market by Test, 2021-2031, USD mn 94

Table 18. Canada Clinical Diagnostics Market by Product, 2021-2031, USD mn 94

Table 19. Canada Clinical Diagnostics Market by Indication, 2021-2031, USD mn 94

Table 20. Mexico Clinical Diagnostics Market by Test, 2021-2031, USD mn 96

Table 21. Mexico Clinical Diagnostics Market by Product, 2021-2031, USD mn 96

Table 22. Mexico Clinical Diagnostics Market by Indication, 2021-2031, USD mn 96

Table 23. Europe Clinical Diagnostics Market by Country, 2021-2031, USD mn 100

Table 24. Germany Clinical Diagnostics Market by Test, 2021-2031, USD mn 102

Table 25. Germany Clinical Diagnostics Market by Product, 2021-2031, USD mn 102

Table 26. Germany Clinical Diagnostics Market by Indication, 2021-2031, USD mn 102

Table 27. U.K. Clinical Diagnostics Market by Test, 2021-2031, USD mn 104

Table 28. U.K. Clinical Diagnostics Market by Product, 2021-2031, USD mn 104

Table 29. U.K. Clinical Diagnostics Market by Indication, 2021-2031, USD mn 104

Table 30. France Clinical Diagnostics Market by Test, 2021-2031, USD mn 106

Table 31. France Clinical Diagnostics Market by Product, 2021-2031, USD mn 106

Table 32. France Clinical Diagnostics Market by Indication, 2021-2031, USD mn 106

Table 33. Spain Clinical Diagnostics Market by Test, 2021-2031, USD mn 108

Table 34. Spain Clinical Diagnostics Market by Product, 2021-2031, USD mn 108

Table 35. Spain Clinical Diagnostics Market by Indication, 2021-2031, USD mn 108

Table 36. Italy Clinical Diagnostics Market by Test, 2021-2031, USD mn 110

Table 37. Italy Clinical Diagnostics Market by Product, 2021-2031, USD mn 110

Table 38. Italy Clinical Diagnostics Market by Indication, 2021-2031, USD mn 110

Table 39. Russia Clinical Diagnostics Market by Test, 2021-2031, USD mn 112

Table 40. Russia Clinical Diagnostics Market by Product, 2021-2031, USD mn 112

Table 41. Russia Clinical Diagnostics Market by Indication, 2021-2031, USD mn 112

Table 42. Clinical Diagnostics Market in Rest of Europe by Country, 2021-2031, USD mn 114

Table 43. APAC Clinical Diagnostics Market by Country, 2021-2031, USD mn 117

Table 44. Japan Clinical Diagnostics Market by Test, 2021-2031, USD mn 121

Table 45. Japan Clinical Diagnostics Market by Product, 2021-2031, USD mn 121

Table 46. Japan Clinical Diagnostics Market by Indication, 2021-2031, USD mn 121

Table 47. China Clinical Diagnostics Market by Test, 2021-2031, USD mn 123

Table 48. China Clinical Diagnostics Market by Product, 2021-2031, USD mn 123

Table 49. China Clinical Diagnostics Market by Indication, 2021-2031, USD mn 123

Table 50. Australia Clinical Diagnostics Market by Test, 2021-2031, USD mn 125

Table 51. Australia Clinical Diagnostics Market by Product, 2021-2031, USD mn 125

Table 52. Australia Clinical Diagnostics Market by Indication, 2021-2031, USD mn 125

Table 53. India Clinical Diagnostics Market by Test, 2021-2031, USD mn 127

Table 54. India Clinical Diagnostics Market by Product, 2021-2031, USD mn 127

Table 55. India Clinical Diagnostics Market by Indication, 2021-2031, USD mn 127

Table 56. South Korea Clinical Diagnostics Market by Test, 2021-2031, USD mn 129

Table 57. South Korea Clinical Diagnostics Market by Product, 2021-2031, USD mn 129

Table 58. South Korea Clinical Diagnostics Market by Indication, 2021-2031, USD mn 129

Table 59. Clinical Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, USD mn 131

Table 60. South America Clinical Diagnostics Market by Country, 2021-2031, USD mn 134

Table 61. Argentina Clinical Diagnostics Market by Test, 2021-2031, USD mn 136

Table 62. Argentina Clinical Diagnostics Market by Product, 2021-2031, USD mn 136

Table 63. Argentina Clinical Diagnostics Market by Indication, 2021-2031, USD mn 136

Table 64. Brazil Clinical Diagnostics Market by Test, 2021-2031, USD mn 138

Table 65. Brazil Clinical Diagnostics Market by Product, 2021-2031, USD mn 138

Table 66. Brazil Clinical Diagnostics Market by Indication, 2021-2031, USD mn 138

Table 67. Chile Clinical Diagnostics Market by Test, 2021-2031, USD mn 140

Table 68. Chile Clinical Diagnostics Market by Product, 2021-2031, USD mn 140

Table 69. Chile Clinical Diagnostics Market by Indication, 2021-2031, USD mn 140

Table 70. MEA Clinical Diagnostics Market by Country, 2021-2031, USD mn 144

Table 71. UAE Clinical Diagnostics Market by Test, 2021-2031, USD mn 146

Table 72. UAE Clinical Diagnostics Market by Product, 2021-2031, USD mn 146

Table 73. UAE Clinical Diagnostics Market by Indication, 2021-2031, USD mn 146

Table 74. Saudi Arabia Clinical Diagnostics Market by Test, 2021-2031, USD mn 148

Table 75. Saudi Arabia Clinical Diagnostics Market by Product, 2021-2031, USD mn 148

Table 76. Saudi Arabia Clinical Diagnostics Market by Indication, 2021-2031, USD mn 148

Table 77. South Africa Clinical Diagnostics Market by Test, 2021-2031, USD mn 150

Table 78. South Africa Clinical Diagnostics Market by Product, 2021-2031, USD mn 150

Table 79. South Africa Clinical Diagnostics Market by Indication, 2021-2031, USD mn 150

Table 80. Abbott Laboratories: Company Snapshot 156

Table 81. Abbott Laboratories: Business Segmentation 157

Table 82. Abbott Laboratories: Product Portfolio 157

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us

Want the same for your business? Talk To Our Expert